The Food and Drug Administration (FDA) announced that it has approved the first-ever treatment for early-stage dementia and ...

An Alzheimer’s drug could prevent dementia before symptoms show, with research suggesting it could clear toxic brain plaques ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Renée ...

Adults living with Alzheimer’s-related dementia now have a second FDA-approved drug for agitation, and for the first time, ...

A drug that has passed phase 1 trials for spinal injuries in people repaired DNA breaks and reduced inflammation in mouse ...

Eisai and Biogen won approval from the Food and Drug Administration for an injection of their Leqembi Iqlik drug as an initiation dose to treat early Alzheimer's disease. The companies said Monday the ...

Programs that match caregivers with patient navigators yield better outcomes than Alzheimer's drug – but combining the two may be best. A Medicare-covered program that offers support and medical ...

Medicine may slow decline for some, but dementia care must also protect dignity, identity and story when speech begins to fade.

If you look inside your medicine cabinet, there’s likely some good news and bad news when it comes to brain health. A few common medications, like statins or drugs to treat high blood pressure, appear ...

Patients prescribed gabapentin 12 or more times had a 40% higher likelihood of dementia and a 65% increased risk of MCI compared to those prescribed the drug fewer times. (CREDIT: CC BY-SA 4.0) Close ...

More than 7 million Americans aged 65 and older have Alzheimer's disease, the most common form of dementia. Yet average wait times for a dementia diagnosis range from 12 months to nearly four years.